Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Westlake Chemical Partners (WLKP) Common Equity (2016 - 2025)

Historic Common Equity for Westlake Chemical Partners (WLKP) over the last 13 years, with Q3 2025 value amounting to $813.3 million.

  • Westlake Chemical Partners' Common Equity fell 292.46% to $813.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $813.3 million, marking a year-over-year decrease of 292.46%. This contributed to the annual value of $829.3 million for FY2024, which is 314.58% down from last year.
  • As of Q3 2025, Westlake Chemical Partners' Common Equity stood at $813.3 million, which was down 292.46% from $831.2 million recorded in Q2 2025.
  • In the past 5 years, Westlake Chemical Partners' Common Equity ranged from a high of $976.2 million in Q1 2022 and a low of $803.1 million during Q1 2025
  • For the 5-year period, Westlake Chemical Partners' Common Equity averaged around $885.1 million, with its median value being $868.0 million (2023).
  • As far as peak fluctuations go, Westlake Chemical Partners' Common Equity soared by 691.31% in 2022, and later tumbled by 1042.2% in 2023.
  • Over the past 5 years, Westlake Chemical Partners' Common Equity (Quarter) stood at $972.7 million in 2021, then dropped by 7.09% to $903.7 million in 2022, then decreased by 5.25% to $856.2 million in 2023, then decreased by 3.15% to $829.3 million in 2024, then dropped by 1.93% to $813.3 million in 2025.
  • Its Common Equity stands at $813.3 million for Q3 2025, versus $831.2 million for Q2 2025 and $803.1 million for Q1 2025.